Unknown

Dataset Information

0

Post-thaw application of ROCK-inhibitors increases cryopreserved T-cell yield.


ABSTRACT: Emerging cell-based therapies such as CAR-T (Chimeric Antigen Receptor T) cells require cryopreservation to store and deliver intact and viable cells. Conventional cryopreservation formulations use DMSO to mitigate cold-induced damage, but do not address all the biochemical damage mechanisms induced by cold stress, such as programmed cell death (apoptosis). Rho-associated protein kinases (ROCK) are a key component of apoptosis, and their activation contributes to apoptotic blebbing. Here we demonstrate that the ROCK inhibitor fasudil hydrochloride, when supplemented into the thawing medium of T-cells increases the overall yield of healthy cells. Cell yield was highest using 5 or 10% DMSO cryopreservation solutions, with lower DMSO concentrations (2.5%) leading to significant physical damage to the cells. After optimisation, the post-thaw yield of T-cells increased by approximately 20% using this inhibitor, a significant increase in the context of a therapy. Flow cytometry analysis did not show a significant reduction in the relative percentage of cell populations undergoing apoptosis, but there was a small reduction in the 8 hours following thawing. Fasudil also led to a reduction in reactive oxygen species. Addition of fasudil into the cryopreservation solution, followed by dilution (rather than washing) upon thaw also gave a 20% increase in cell yield, demonstrating how this could be deployed in a cell-therapy context, without needing to change clinical thawing routines. Overall, this shows that modulation of post-thaw biochemical pathways which lead to apoptosis (or other degradative pathways) can be effectively targeted as a strategy to increase T-cell yield and function post-thaw.

SUBMITTER: Gonzalez-Martinez N 

PROVIDER: S-EPMC10583820 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Post-thaw application of ROCK-inhibitors increases cryopreserved T-cell yield.

Gonzalez-Martinez Natalia N   Gibson Matthew I MI  

RSC medicinal chemistry 20230905 10


Emerging cell-based therapies such as CAR-T (Chimeric Antigen Receptor T) cells require cryopreservation to store and deliver intact and viable cells. Conventional cryopreservation formulations use DMSO to mitigate cold-induced damage, but do not address all the biochemical damage mechanisms induced by cold stress, such as programmed cell death (apoptosis). Rho-associated protein kinases (ROCK) are a key component of apoptosis, and their activation contributes to apoptotic blebbing. Here we demo  ...[more]

Similar Datasets

2019-01-02 | PXD010533 | Pride
| S-EPMC5466057 | biostudies-literature
2016-12-30 | GSE88946 | GEO
| S-EPMC9953348 | biostudies-literature
| S-EPMC8221256 | biostudies-literature
| S-EPMC7552309 | biostudies-literature
| S-EPMC11650631 | biostudies-literature
| S-EPMC11611725 | biostudies-literature
| S-EPMC6044699 | biostudies-literature
| S-EPMC8277125 | biostudies-literature